Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company has developed a non-invasive diagnostic technology using Raman laser and infrared spectroscopy to detect spectroscopic biomarkers in blood. Its initial focus is on early detection of Alzheimer’s disease, aiming to replace invasive procedures like lumbar puncture with a simple blood test. The approach promises faster, less invasive, and more cost-effective diagnostics compared to current imaging or CSF-based methods. No clinical trial results have been published yet as the company remains at an early development stage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raman Health Technologies.